Literature DB >> 31277928

Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies.

Cianna Leatherwood1, Cameron B Speyer1, Candace H Feldman1, Kristin D'Silva2, José A Gómez-Puerta3, Paul J Hoover1, Sushrut S Waikar4, Gearoid M McMahon4, Helmut G Rennke5, Karen H Costenbader6.   

Abstract

BACKGROUND: Interstitial fibrosis and tubular atrophy (IFTA) and vascular injury are frequent histologic features of lupus nephritis renal biopsies, but their clinical correlates and prognostic value are not well understood. This cohort study investigated demographic, clinical and laboratory characteristics, and outcomes, associated with IFTA and vascular injury in lupus nephritis.
METHODS: Reports of all renal biopsies performed at an academic medical center (1990-2017) with WHO/ISN/RPS Class II-V lupus nephritis were reviewed. Demographics, clinical variables and labs at biopsy, treatment, and date of death were collected. Additional data from the U.S. Renal Data System (USRDS) provided dates of ESRD and death after ESRD. Multivariable regression analyses identified demographic and clinical factors associated with each histologic finding. Cumulative incidence functions and multivariable Cox proportional hazard models estimated the risk of progression to ESRD and death.
RESULTS: Within 202 initial biopsies, IFTA was associated with the patient's SLICC/ACR damage index (without renal domain) and serum creatinine, and vascular injury was associated with serum creatinine in multivariable models. In Cox regression models adjusting for age, sex, race, serum creatinine, calendar year, and biopsy class, moderate/severe IFTA was associated with elevated ESRD (HRSD 5.18, 95% CI 2.53, 10.59) and death (HR 4.19, 95%CI 1.27, 13.81). After adjustment for age, sex and race, moderate/severe vascular injury was associated with ESRD (HRSD 2.13, 95% CI 1.21, 3.75) and but this relationship was not significant after adjustment for serum creatinine and calendar year.
CONCLUSIONS: IFTA is a strong predictor of ESRD and death, even in proliferative nephritis, and a risk factor for poor outcomes independent of class. Vascular injury is a strong predictor of prognosis, but not independent of serum creatinine and class. The prognostic value of these lesions calls for consideration when determining treatment for lupus nephritis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Interstitial fibrosis; Lupus nephritis; Pathology; Tubular atrophy; Vascular injury

Year:  2019        PMID: 31277928      PMCID: PMC6888990          DOI: 10.1016/j.semarthrit.2019.06.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  40 in total

1.  Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy.

Authors:  Fabio Pagni; Stefania Galimberti; Eleonora Galbiati; Paola Rebora; Veronica Pietropaolo; Federico Pieruzzi; Andrew James Smith; Franco Ferrario
Journal:  Nephrology (Carlton)       Date:  2016-01       Impact factor: 2.506

2.  Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Authors:  Anna Broder; Wenzhu B Mowrey; Hina N Khan; Bojana Jovanovic; Alejandra Londono-Jimenez; Peter Izmirly; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2017-07-14       Impact factor: 5.532

3.  Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.

Authors:  J F Merola; B Bermas; B Lu; E W Karlson; E Massarotti; P H Schur; K H Costenbader
Journal:  Lupus       Date:  2014-03-07       Impact factor: 2.911

4.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Authors:  Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O Utset; Marcus R Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

Review 5.  The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.

Authors:  Marcus R Clark; Kimberly Trotter; Anthony Chang
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

6.  Relationship between vascular disease and age-associated changes in the human kidney.

Authors:  B L Kasiske
Journal:  Kidney Int       Date:  1987-05       Impact factor: 10.612

Review 7.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

8.  Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification.

Authors:  G B Appel; F G Silva; C L Pirani; J I Meltzer; D Estes
Journal:  Medicine (Baltimore)       Date:  1978-09       Impact factor: 1.889

9.  Histopathological Association between Vascular Hypertensive Changes and Different Types of Glomerulopathies.

Authors:  Aber Halim Baki; Yasser Soliman; Elham Ibrahim Seif
Journal:  Arab J Nephrol Transplant       Date:  2014-01

Review 10.  Update on the Native Kidney Biopsy: Core Curriculum 2019.

Authors:  Randy L Luciano; Gilbert W Moeckel
Journal:  Am J Kidney Dis       Date:  2019-01-17       Impact factor: 8.860

View more
  10 in total

1.  Beyond ISN/RPS Lupus Nephritis Classification: Adding Chronicity Index to Clinical Variables Predicts Kidney Survival.

Authors:  Gabriella Moroni; Giulia Porata; Francesca Raffiotta; Silvana Quaglini; Giulia Frontini; Lucia Sacchi; Valentina Binda; Marta Calatroni; Francesco Reggiani; Giovanni Banfi; Claudio Ponticelli
Journal:  Kidney360       Date:  2021-11-05

2.  Prognostic Implications of a Morphometric Evaluation for Chronic Changes on All Diagnostic Native Kidney Biopsies.

Authors:  Aleksandar Denic; Marija Bogojevic; Aidan F Mullan; Moldovan Sabov; Muhammad S Asghar; Sanjeev Sethi; Maxwell L Smith; Fernando C Fervenza; Richard J Glassock; Musab S Hommos; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2022-08-03       Impact factor: 14.978

Review 3.  Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2020-03-19       Impact factor: 20.543

Review 4.  Management of Lupus Nephritis.

Authors:  Farah Tamirou; Frédéric A Houssiau
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

5.  Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Marta Casal Moura; Fernando C Fervenza; Ulrich Specks; Sanjeev Sethi
Journal:  Nephrol Dial Transplant       Date:  2022-08-22       Impact factor: 7.186

6.  Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.

Authors:  Chunzhen Li; Yanan Han; Lili Zhang; Zhiguo Chen; Mei Jin; Suzhen Sun
Journal:  BMC Nephrol       Date:  2022-08-26       Impact factor: 2.585

Review 7.  Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.

Authors:  Leonardo Palazzo; Julius Lindblom; Chandra Mohan; Ioannis Parodis
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

8.  circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis.

Authors:  Junjun Luan; Congcong Jiao; Cong Ma; Yixiao Zhang; Xiangnan Hao; Guangyu Zhou; Jingqi Fu; Xingyu Qiu; Hongyu Li; Wei Yang; Gabor G Illei; Jeffrey B Kopp; Jingbo Pi; Hua Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-10-11       Impact factor: 7.310

9.  The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis.

Authors:  Ricard Cervera; Luis F Quintana; Manuel Ferreira Gomes; Claudia Mardones; Marc Xipell; Miquel Blasco; Manel Solé; Gerard Espinosa; Adriana García-Herrera
Journal:  J Nephrol       Date:  2021-03-15       Impact factor: 3.902

Review 10.  Cellular aspects of the pathogenesis of lupus nephritis.

Authors:  Anthony Chang; Marcus R Clark; Kichul Ko
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 4.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.